Postural orthostatic tachycardia syndrome in post SARS-CoV-2 patients
DOI:
https://doi.org/10.55204/trc.v3i2.e121Keywords:
Postural orthostatic tachycardia syndrome, COVID-19, signs and symptoms, therapy, pathophysiologyAbstract
This review focused on describing postural orthostatic tachycardia syndrome in post-SARS-CoV-2 patients. For this purpose, a narrative literature review study was carried out, using bibliographic descriptors such as DeCS and MeSH in PubMed and Science Direct databases to obtain scientific articles from the period 2019-2022. In addition, we used Boléan connectors such as "OR-NOT-AND" and keywords in Spanish and English. Thirteen articles were identified, of which most of them report palpitations, lightheadedness, orthostatic headache, orthostatic tachycardia as the main symptoms, possibly associated with the alteration of autonomic fibers. The pathophysiological mechanism that produces this syndrome is not known exactly, but it is believed that it is triggered after a viral infection such as SARS-CoV-2. The treatment of choice for this condition in individuals who have overcome the infection by COVID-19 is the application of non-pharmacological measures whose objective is to improve the patient's symptomatology, however, if these measures are not sufficient, pharmacological therapy can be used where one of the drugs administered whose effect is very beneficial is ivabradine, although some therapies such as enhanced external counterpulsation and stellate ganglion blockade are currently under investigation.
Downloads
References
Agnihotri, S. P., Luis, C. V. S., & Kazamel, M. (2022). Autonomic neuropathy as post-acute sequela of SARS-CoV-2 infection: A case report. Journal of Neurovirology, 28(1), 158-161. https://doi.org/10.1007/s13365-022-01056-5
Blitshteyn, S., & Whitelaw, S. (2021). Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: A case series of 20 patients. Immunologic Research, 69(2), 205-211. https://doi.org/10.1007/s12026-021-09185-5
Blitshteyn, S., & Fedorowski, A. (2022). The risks of POTS after COVID-19 vaccination and SARS-CoV-2 infection: It’s worth a shot. Nature Cardiovascular Research, 1(12), Art. 12. https://doi.org/10.1038/s44161-022-00180-z
Chadda, K. R., Blakey, E. E., Huang, C. L.-H., & Jeevaratnam, K. (2022). Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed? Frontiers in Cardiovascular Medicine, 9, 860198. https://doi.org/10.3389/fcvm.2022.860198
Fedorowski, A. (2019). Postural orthostatic tachycardia syndrome: Clinical presentation, aetiology and management. Journal of Internal Medicine, 285(4), 352-366. https://doi.org/10.1111/joim.12852
Fu, Q., & Levine, B. D. (2018). Exercise and non-pharmacological treatment of POTS. Autonomic Neuroscience: Basic & Clinical, 215, 20-27. https://doi.org/10.1016/j.autneu.2018.07.001
Fu, Q., Vangundy, T. B., Galbreath, M. M., Shibata, S., Jain, M., Hastings, J. L., Bhella, P. S., & Levine, B. D. (2010). Cardiac origins of the postural orthostatic tachycardia syndrome. Journal of the American College of Cardiology, 55(25), 2858-2868. https://doi.org/10.1016/j.jacc.2010.02.043
Ganesh, R., Bonnes, S. L. R., & DiBaise, J. K. (2020). Postural Tachycardia Syndrome: Nutrition Implications. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition, 35(5), 818-825. https://doi.org/10.1002/ncp.10564
Garland, E. M., Gamboa, A., Nwazue, V. C., Celedonio, J. E., Paranjape, S. Y., Black, B. K., Okamoto, L. E., Shibao, C. A., Biaggioni, I., Robertson, D., Diedrich, A., Dupont, W. D., & Raj, S. R. (2021). Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome. Journal of the American College of Cardiology, 77(17), 2174-2184. https://doi.org/10.1016/j.jacc.2021.03.005
Gee, M. E., Watkins, A. K., Brown, J. N., & Young, E. J. A. (2018). Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review. American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions, 18(3), 195-204. https://doi.org/10.1007/s40256-017-0252-1
Goldstein, D. S. (2021). The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm, 18(4), 508-509. https://doi.org/10.1016/j.hrthm.2020.12.007
Harris, C. I. (2022). COVID-19 Increases the Prevalence of Postural Orthostatic Tachycardia Syndrome: What Nutrition and Dietetics Practitioners Need to Know. Journal of the Academy of Nutrition and Dietetics, 122(9), 1600-1605. https://doi.org/10.1016/j.jand.2022.06.002
Hermel, M., Sweeney, M., Abud, E., Luskin, K., Criado, J. P., Bonakdar, R., Gray, J., & Ahern, T. (2022). COVID-19 Vaccination Might Induce Postural Orthostatic Tachycardia Syndrome: A Case Report. Vaccines, 10(7). https://doi.org/10.3390/vaccines10070991
Kavi, L. (2022). Postural tachycardia syndrome and long COVID: An update. The British Journal of General Practice: The Journal of the Royal College of General Practitioners, 72(714), 8-9. https://doi.org/10.3399/bjgp22X718037
Liu, L. D., & Duricka, D. L. (2022). Stellate ganglion block reduces symptoms of Long COVID: A case series. Journal of Neuroimmunology, 362, 577784. https://doi.org/10.1016/j.jneuroim.2021.577784
Miglis, M. G., Prieto, T., Shaik, R., Muppidi, S., Sinn, D.-I., & Jaradeh, S. (2020). A case report of postural tachycardia syndrome after COVID-19. Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society, 30(5), 449-451. https://doi.org/10.1007/s10286-020-00727-9
Ormiston, C. K., Świątkiewicz, I., & Taub, P. R. (2022). Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm, S1547-5271(22)02185-3. https://doi.org/10.1016/j.hrthm.2022.07.014
Park, J., Kim, S., Lee, J., & An, J. Y. (2022). A case of transient POTS following COVID-19 vaccine. Acta Neurologica Belgica, 122(4), 1081-1083. https://doi.org/10.1007/s13760-022-02002-2
Raj, S. R., Bourne, K. M., Stiles, L. E., Miglis, M. G., Cortez, M. M., Miller, A. J., Freeman, R., Biaggioni, I., Rowe, P. C., Sheldon, R. S., Shibao, C. A., Diedrich, A., Systrom, D. M., Cook, G. A., Doherty, T. A., Abdallah, H. I., Grubb, B. P., Fedorowski, A., Stewart, J. M., Vernino, S. (2021). Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting – Part 2. Autonomic Neuroscience, 235, 102836. https://doi.org/10.1016/j.autneu.2021.102836
Raj, S. R., Arnold, A. C., Barboi, A., Claydon, V. E., Limberg, J. K., Lucci, V.-E. M., Numan, M., Peltier, A., Snapper, H., Vernino, S., & American Autonomic Society. (2021). Long-COVID postural tachycardia syndrome: An American Autonomic Society statement. Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society, 31(3), 365-368. https://doi.org/10.1007/s10286-021-00798-2
Sandroni, P., Opfer-Gehrking, T. L., McPhee, B. R., & Low, P. A. (1999). Postural tachycardia syndrome: Clinical features and follow-up study. Mayo Clinic Proceedings, 74(11), 1106-1110. https://doi.org/10.4065/74.11.1106
Savytskyi, I. V., Pruc, M., Malysz, M., Maslyukov, A., & Szarpak, L. (2022). Post-COVID-19 postural orthostatic tachycardia syndrome. Cardiology Journal, 29(3), 531-532. https://doi.org/10.5603/CJ.a2022.0021
Schofield, J. R. (2021). Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On. European Journal of Case Reports in Internal Medicine, 8(3), 002378. https://doi.org/10.12890/2021_002378
Shouman, K., Vanichkachorn, G., Cheshire, W. P., Suarez, M. D., Shelly, S., Lamotte, G. J., Sandroni, P., Benarroch, E. E., Berini, S. E., Cutsforth-Gregory, J. K., Coon, E. A., Mauermann, M. L., Low, P. A., & Singer, W. (2021). Autonomic dysfunction following COVID-19 infection: An early experience. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society, 31(3), 385-394. https://doi.org/10.1007/s10286-021-00803-8
Taub, P. R., Zadourian, A., Lo, H. C., Ormiston, C. K., Golshan, S., & Hsu, J. C. (2021). Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome. Journal of the American College of Cardiology, 77(7), 861-871. https://doi.org/10.1016/j.jacc.2020.12.029
Thieben, M. J., Sandroni, P., Sletten, D. M., Benrud-Larson, L. M., Fealey, R. D., Vernino, S., Lennon, V. A., Shen, W.-K., & Low, P. A. (2007). Postural orthostatic tachycardia syndrome: The Mayo clinic experience. Mayo Clinic Proceedings, 82(3), 308-313. https://doi.org/10.4065/82.3.308
Trisvetova, E. L. (2022). Postural Orthostatic Tachycardia Syndrome as a Manifestation of Post-COVID-19 Syndrome. Rational Pharmacotherapy in Cardiology, 18(2), Art. 2. https://doi.org/10.20996/1819-6446-2022-04-11
Varanasi, S., Sathyamoorthy, M., Chamakura, S., & Shah, S. A. (2021). Management of Long-COVID Postural Orthostatic Tachycardia Syndrome With Enhanced External Counterpulsation. Cureus, 13(9), e18398. https://doi.org/10.7759/cureus.18398
Zadourian, A., Doherty, T. A., Swiatkiewicz, I., & Taub, P. R. (2018). Postural Orthostatic
Vyas, R., Nesheiwat, Z., Ruzieh, M., Ammari, Z., Al-Sarie, M., & Grubb, B. (2020). Bupropion in the treatment of postural orthostatic tachycardia syndrome (POTS): A single-center experience. Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research, 68(6), 1156-1158. https://doi.org/10.1136/jim-2020-001272
Zadourian A, Doherty T, Swiatkiewicz I, Taub P. Tachycardia Syndrome: Prevalence, Pathophysiology, and Management. Drugs, 78(10), 983-994. https://doi.org/10.1007/s40265-018-0931-5
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Wagner Chica Gallardo, Julio Ojeda Sánchez, Briyit Romero Añazco, Santiago Sánchez Peralta
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the moral and patrimonial rights of their works. They only give to the magazine Tesla Revista Científica the right to the first publication of this. Since Tesla Revista Científica is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself. Tesla Revista Científica undertakes not to make commercial use of the texts it receives and/or publishes.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
